Pfizer jacks up price for five-day course of COVID drug Paxlovid

Pfizer plans to charge COVID patients around $1,400 for a five-day course of the antiviral drug Paxlovid.

Related Keywords

Germany ,German ,Albert Bourla ,David Hoskins ,Eric Feigl ,Johnson ,Congressional Budget Office ,Drug Administration ,Pfizer ,Reuters ,Wall Street ,Business ,Covid Vaccine ,Pharmaceuticals ,Vaccines ,